Background: Given the important association between cardiovascular disease and cognitive decline, and their significant implications on frailty status, the contribution of neurocognitive frailty measure helping with the assessment of patient outcomes is dearly needed.
Objectives: The present study examines the prognostic value of the Neurocognitive Frailty Index (NFI) in the elderly with cardiovascular disease.
Design: Secondary analysis of the Canadian Study of Health and Aging (CSHA) dataset was used for prediction of 5-year cognitive changes.
Setting: Community and institutional sample.
Participants: Canadians aged 65 and over [Mean age: 80.4 years (SD=6.9; Range of 66-100)].
Measurement: Neurocognitive Frailty Index (NFI) and Modified Mini-Mental State (3MS) scores for cognitive functioning of all subjects at follow-up and mortality rate were measured.
Results: The NFI mean score was 9.63 (SD = 6.04) and ranged from 0 to 33. This study demonstrated that the NFI was significantly associated with cognitive changes for subjects with heart disease and this correlation was a stronger predictor than age.
Conclusion: The clinical relevance of this study is that our result supports the prognostic utility of the NFI tool in treatment planning for those with modifiable cardiovascular disease risk factors in the development of dementia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.14283/jfa.2020.21 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Under-recognised neurocognitive deficits in adults and adolescents with tuberous sclerosis complex.
J Med Genet
January 2025
Department of Neurosciences, Université de Montréal, Montreal, Québec, Canada
Background: Tuberous sclerosis complex (TSC) is a genetic disease characterised by the growth of benign tumours. The Tuberous sclerosis Associated Neuropsychiatric Disorders (TAND) Checklist is used to identify patient-reported neurocognitive deficits. Patients may, however, under-recognise mild cognitive impairment.
View Article and Find Full Text PDFFrailty and neurocognitive impairments in Chinese survivors of childhood cancer.
J Cancer Surviv
January 2025
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Purpose: This study aimed to evaluate the prevalence and predictors of frailty and the association between frailty and neurocognitive impairments among Chinese survivors of childhood cancer.
Methods: A total of 185 survivors of childhood cancer were recruited from a long-term follow-up clinic in Hong Kong (response rate: 94.4%; 48.
Developing an HIV-specific falls risk prediction model with a novel clinical index: a systematic review and meta-analysis method.
BMC Infect Dis
December 2024
Department of Nursing Sciences, Faculty of Health Sciences & Technology, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria.
Background: Falls are a common problem experienced by people living with HIV yet predictive models specific to this population remain underdeveloped. We aimed to identify, assess and stratify the predictive strength of various physiological, behavioral, and HIV-specific factors associated with falls among people living with HIV and inform a predictive model for fall prevention.
Methods: Systematic review and meta-analysis were conducted to explore predictors of falls in people living with HIV.
Individualizing Antiretroviral Therapy in the Older Patient.
Drugs Aging
January 2025
Department of Infectious Diseases, Alfred Hospital and Monash University, 55 Commercial Rd, Melbourne, VIC, 3004, Australia.
Owing to widespread availability of potent and tolerable antiretroviral therapy, life expectancy of people with human immunodeficiency virus (HIV) has significantly increased. Consequently, the population of people with HIV are ageing, with over 50% over the age of 50 years, and it is expected that 25% will be over the age of 65 years by 2030. People diagnosed with HIV at older age tend to have more advanced disease, and may already be experiencing comorbidities that will influence the choice of initial antiretroviral treatment.
View Article and Find Full Text PDFCognition in patients with mild autonomous cortisol secretion at baseline and post-adrenalectomy.
Eur J Endocrinol
November 2024
Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, United States.
Objectives: The impact of mild autonomous cortisol secretion (MACS) on cognition is incompletely characterized. We aimed to assess cognition in patients with MACS, identify factors associated with lower cognition, and determine the impact of adrenalectomy on cognition.
Methods: We conducted a cross-sectional study (4/2019 to 10/2022) and a longitudinal cohort study (10/2021 to 9/2023) of adults with MACS and referent subjects.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!